Home Mechanical Ventilation for Chronic Respiratory Failure
For patients with chronic respiratory failure, nocturnal noninvasive ventilation (NIV) should be the first-line approach for most conditions, particularly in chronic stable hypercapnic COPD (PaCO₂ >45 mmHg), with high-intensity settings targeting normalization of PaCO₂, while invasive ventilation via tracheostomy is reserved for neuromuscular diseases, failed weaning, or when NIV is not tolerated. 1, 2
Patient Selection and Indications
Noninvasive Ventilation Candidates
- Initiate nocturnal NIV for chronic stable hypercapnic respiratory failure when patients have documented hypercapnia (PaCO₂ >45 mmHg) with symptoms of ventilatory failure, particularly in COPD, restrictive lung diseases, obesity-hypoventilation syndrome, and neuromuscular disorders 1, 3
- Screen all patients for obstructive sleep apnea before starting long-term NIV, as this significantly impacts ventilator settings and outcomes 1, 2
- Do not initiate long-term NIV during acute-on-chronic hypercapnic respiratory failure; instead, reassess 2-4 weeks after resolution of the acute episode 1
- Consider long-term domiciliary NIV for COPD patients who have had three or more episodes of acute hypercapnic respiratory failure in the previous year 1
Invasive Ventilation Candidates
- Patients with neuromuscular disease or spinal cord lesions who develop acute hypercapnic respiratory failure should be referred to specialized centers for assessment of long-term invasive ventilation 1
- Consider tracheostomy for patients with chronic respiratory failure when there is failure to wean from NIV after one week, or when NIV is not tolerated despite optimization 1
- Tracheostomy should be discussed in multidisciplinary fashion for patients with progressive neuromuscular disorders (e.g., ALS), recognizing that it does not alter disease prognosis but may facilitate management 1
Ventilator Settings and Titration Strategy
High-Intensity NIV Protocol
- Use bi-level pressure support ventilation with initial IPAP of 10-15 cmH₂O and EPAP of 4-8 cmH₂O, maintaining a pressure difference of at least 5 cmH₂O 2
- Set backup respiratory rate equal to or slightly less than the patient's spontaneous sleeping respiratory rate (minimum 10 breaths/min) 2
- Target normalization of PaCO₂ rather than modest reduction, as this approach improves physiological parameters, clinical symptoms, and patient-centered outcomes including hospital readmission and survival 1, 2
- For patients with comorbid sleep apnea, higher EPAP settings may be required to maintain upper airway patency during sleep 2
Titration Approach
- In-laboratory polysomnography is not necessary for NIV titration in chronic stable hypercapnic COPD patients 1, 2
- Check arterial blood gases after 30-60 minutes of ventilation and monitor regularly to ensure effective PaCO₂ reduction 2
- Adjust settings based on clinical response, with most patients showing improvement in PaO₂, pH, and PaCO₂ within 1-4 hours if NIV will be successful 1
Essential Equipment and Safety Requirements
For Noninvasive Ventilation
- Primary ventilator with appropriate interface (facial mask)
- Backup ventilator for patients who cannot tolerate being off ventilation for >6 hours 1
- Battery backup and alternative power sources 1
- Pulse oximeter for monitoring, especially during sleep 1
- Self-inflating bag and mask for emergency use 1
For Invasive Ventilation
- Primary ventilator designed for home use
- Mandatory backup ventilator for all tracheostomy patients 1
- Batteries and generator backup 1
- Portable suction equipment 1
- Heated humidifier 1
- Supplemental oxygen for emergency use 1
- Mechanical insufflation-exsufflation (MI-E) device for patients with ineffective cough, particularly those with neuromuscular disease 1
Monitoring and Follow-Up
Pre-Discharge Assessment
- All patients treated with NIV for acute hypercapnic respiratory failure must undergo spirometry and arterial blood gas analysis while breathing room air before discharge 1
- If PaO₂ <7.3 kPa in COPD patients, repeat measurement after at least 3 weeks 1
- Ensure patient demonstrates stability on chosen home device before discharge 1
Ongoing Monitoring
- Monitor with pulse oximetry during sleep or when unobserved, rather than relying solely on ventilator alarms 1
- Regular maintenance of ventilators and equipment as outlined by manufacturer 1
- Recognize that ventilator performance in the home may vary considerably, with potential differences between set and delivered settings placing patients at risk for hypoventilation 1
Critical Pitfalls and Complications
Common Challenges
- Patient compliance decreases over time, even over short periods, requiring ongoing support and monitoring 2
- Equipment malfunction is related to age of equipment, longer intervals between servicing, and inadequate caregiver maintenance 1
- When transitioning between ventilator types (internal vs. external PEEP), required settings may differ significantly to achieve equivalent support 1
- Home ventilators vary in their ability to reliably deliver specified tidal volumes and compensate for air leaks 1
Safety Considerations
- Provision of appropriate backup supplies decreases risk of ventilator malfunction and associated mortality 1
- Deaths secondary to ventilator failure are rare when proper backup equipment is available 1
- Quality of life and happiness may be significantly reduced after one year of long-term ventilation, requiring individualized assessment of continued indication 4
Organizational Requirements
Specialized Center Involvement
- Home mechanical ventilation must be organized around a specialized respiratory care center with expertise in patient selection, initiation, and control 3, 5
- Patients requiring invasive ventilation should be referred to centers providing long-term ventilation at home 1
- Qualification of specialized home-care services is essential for successful outcomes 3, 5
Ethical Considerations
- Patients receiving home mechanical ventilation should receive routine outpatient palliative care 4
- The indication for continued long-term ventilation should be assessed individually and critically, considering prognosis and quality of life 4
- In progressive neuromuscular diseases, patients and families must understand that tracheostomy facilitates management but does not alter disease prognosis 1